Ensign Group/$ENSG
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Ensign Group
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
- Ticker
- $ENSG
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 46,000
- Headquarters
- San Juan Capistrano, United States
- Website
- ensigngroup.net
Ensign Group Metrics
BasicAdvanced
$11B
27.73
$6.72
0.66
$0.26
0.14%
Price and volume
Market cap
$11B
Beta
0.66
52-week high
$218.00
52-week low
$141.58
Average daily volume
379K
Dividend rate
$0.26
Financial strength
Current ratio
1.199
Quick ratio
1.097
Long term debt to equity
0.844
Total debt to equity
0.892
Dividend payout ratio (TTM)
3.75%
Interest coverage (TTM)
61.92%
Profitability
EBITDA (TTM)
621.525
Gross margin (TTM)
17.10%
Net profit margin (TTM)
7.03%
Operating margin (TTM)
8.85%
Effective tax rate (TTM)
24.98%
Revenue per employee (TTM)
$120,000
Management effectiveness
Return on assets (TTM)
5.59%
Return on equity (TTM)
17.05%
Valuation
Price to earnings (TTM)
27.732
Price to revenue (TTM)
1.897
Price to book
4.21
Price to tangible book (TTM)
4.39
Price to free cash flow (TTM)
21.114
Free cash flow yield (TTM)
4.74%
Free cash flow per share (TTM)
8.824
Dividend yield (TTM)
0.14%
Forward dividend yield
0.14%
Growth
Revenue change (TTM)
17.49%
Earnings per share change (TTM)
20.20%
3-year revenue growth (CAGR)
16.83%
10-year revenue growth (CAGR)
13.53%
3-year earnings per share growth (CAGR)
15.68%
10-year earnings per share growth (CAGR)
22.81%
3-year dividend per share growth (CAGR)
4.17%
10-year dividend per share growth (CAGR)
4.97%
What the Analysts think about Ensign Group
Analyst ratings (Buy, Hold, Sell) for Ensign Group stock.
Analyst projections of the future price of Ensign Group stock.
Bulls say / Bears say
Second-quarter adjusted EPS rose 20.8% year on year, and Ensign raised its 2026 EPS and revenue guidance again. That supports the case that earnings momentum is strong, not just a result of a larger portfolio. (The Ensign Group)
Growth in the established facilities points to improving underlying demand: same-facility occupancy reached 84.1%, while skilled-mix revenue rose 10.1% year on year. A stronger mix of higher-paying skilled patients can support revenue growth beyond acquisitions. (The Ensign Group)
Ensign’s October expansion added operations in Florida, Colorado and Washington, including its first entry into Florida. The additions broaden its geographic reach and create scope to grow by improving acquired facilities over time. (The Ensign Group, Skilled Nursing News)
Ensign remains heavily exposed to public funding: Medicare and Medicaid generated 68.9% of second-quarter service revenue. The company warns that Medicaid financing and payment changes could constrain state reimbursement, while federal Medicare rates can also change. (SEC)
Rapid acquisition growth brings execution risk: management said the 20 recently added operations included many with below-average occupancy and significant clinical and operational hurdles. The recently acquired group already represented 18% of the portfolio, so a slow turnaround could weigh on results. (The Ensign Group, Investing.com)
An investigative report and a short-seller report have alleged staffing shortfalls and irregularities in how some facilities use licensed administrators. These claims are not established findings, but if substantiated they could bring regulatory scrutiny, legal costs and pressure to raise operating expenses. (Hunterbrook, Muddy Waters Research)
Data summarised monthly by Lightyear AI. Last updated on 27 Oct 2026.
Ensign Group Financial Performance
Revenues and expenses
Ensign Group Earnings Performance
Company profitability
Upcoming events
Ensign Group News
AllArticlesVideos
ROSEN, THE FIRST FILING FIRM, Encourages The Ensign Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ENSG
Newsfile Corp10 hours ago
Kaplan Fox & Kilsheimer LLP Encourages The Ensign Group, Inc. (ENSG) Investors With Losses to Seek Appointment as Lead Plaintiff Before December 7, 2026
Newsfile Corp13 hours ago
ENSG SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds The Ensign Group (ENSG) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026
Newsfile Corp22 hours ago
Funds containing Ensign Group
AllUSDEURGBP
Fund name | Fund size | $ENSG weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.58% |
iShares Ageing Population£AGES | $953M | 0.58% |
iShares Ageing Population€AGED | $903M | 0.58% |
SPDR S&P 400 US Mid Cap£SPX4 | $6.4B | 0.31% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.31% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.